Skip to main content
Top
Published in:

05-08-2022 | Ulcerative Colitis | Correspondence

Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease

Authors: Jannis Kountouras, Apostolis Papaefthymiou, Stergios A. Polyzos, Christos Liatsos, Maria Tzitiridou-Chatzopoulou, Dimitrios Chatzopoulos, Elisabeth Vardaka, Dimitra Gialamprinou, Georgios Kotronis, Tharshika Thavayogarajah, Michael Doulberis

Published in: Digestive Diseases and Sciences | Issue 2/2023

Login to get access

Excerpt

To the Editor, …
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease
Authors
Jannis Kountouras
Apostolis Papaefthymiou
Stergios A. Polyzos
Christos Liatsos
Maria Tzitiridou-Chatzopoulou
Dimitrios Chatzopoulos
Elisabeth Vardaka
Dimitra Gialamprinou
Georgios Kotronis
Tharshika Thavayogarajah
Michael Doulberis
Publication date
05-08-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07642-1

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar